Niraparib Plus Pembrolizumab in Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
JASPER: Phase 2 Trial of First-Line Niraparib Plus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer
Cancer 2021 Sep 03;[EPub Ahead of Print], SS Ramalingam, E Thara, MM Awad, A Dowlati, B Haque, TE Stinchcombe, GK Dy, DR Spigel, S Lu, N Iyer Singh, Y Tang, I Teslenko, N IannottiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.